Immune Checkpoint Inhibitor-Associated Thrombotic Thrombocytopenic Purpura in a Patient With Metastatic Non-Small-Cell Lung Cancer.

De Filippis, Samantha; Moore, Colton; Ezell, Kristin; Aggarwal, Kunal; Kelkar, Amar H

De Filippis, Samantha; Moore, Colton; Ezell, Kristin; Aggarwal, Kunal; Kelkar, Amar H.

Afiliação

De Filippis S; Medical Education, University of Medicine and Health Sciences, Camps, KNA.
Moore C; Medical Education, Saint George's University School of Medicine, True Blue, GRD.
Ezell K; Medical Education, Ross University School of Medicine, Miramar, USA.
Aggarwal K; Medical Education, Saint George's University School of Medicine, True Blue, GRD.
Kelkar AH; Division of Hematology and Oncology, University of Florida College of Medicine, Gainesville, USA.

Cureus ; 13(6): e16035, 2021 Jun.

Article em En | MEDLINE | ID: mdl-34345535

Palavras-chave

immune checkpoint inhibitors; immune related adverse events; pembrolizumab; thrombotic microangiopathy; thrombotic thrombocytopenic purpura

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cureus Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google